Correlation Between Cadrenal Therapeutics, and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Lipella Pharmaceuticals.
Diversification Opportunities for Cadrenal Therapeutics, and Lipella Pharmaceuticals
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cadrenal and Lipella is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Lipella Pharmaceuticals
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to under-perform the Lipella Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cadrenal Therapeutics, Common is 1.42 times less risky than Lipella Pharmaceuticals. The stock trades about -0.03 of its potential returns per unit of risk. The Lipella Pharmaceuticals Common is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 330.00 in Lipella Pharmaceuticals Common on August 30, 2024 and sell it today you would lose (35.00) from holding Lipella Pharmaceuticals Common or give up 10.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Lipella Pharmaceuticals |
Cadrenal Therapeutics, and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Lipella Pharmaceuticals
The main advantage of trading using opposite Cadrenal Therapeutics, and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.The idea behind Cadrenal Therapeutics, Common and Lipella Pharmaceuticals Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |